Detection Technology: The group will grow, EBIT yet limited - Evli

DT reports its Q2 results on Thursday, July 3rd. We expect the medical business to bring strong revenue growth while Q2 EBIT is yet limited by cost inflation and stagnant market of China. With moderate valuation, we raise our rating to BUY (HOLD). With adjusted estimates, TP is set at 16.0 (17.5).

Länk till analysen i sin helhet: https://www.evli.com/hubfs/ERP/Raportit/Detection%20Technology/Detection%20Technology%20230731%20Q2%20Preview.pdf